Shinpoong Pharm.co.,LTd : Pipeline

Shin Poong has established a number of overseas branches.: SHINPOONG PHARM.CO.,LTD.

R&D

	Preclinical	Phase 1	Phase 2	Phase 3/4	Marketed
Cardiovascular disease	SP-8257 Stroke, Atherosclerosis	SP-8356 Stroke, Atherosclerosis	CandeAmlo plus™ Hypertension	Otaplimastat (SP-8203) Acute ischemic stroke	CandeAmlo^® Hypertension
Cardiovascular disease					EzeRosu^® Hyperlipidemia
Bone related disease	SP-LI-N1 Sarcopenia Joint steering			Hyaltop^® Osteoarthritis	Hyalflex^® Osteoarthritis
Medical Device	Medicurtain Plus Anti-adhesion +anti-inflammatory				Medicurtain^® Anti-adhesion
Infectious disease				Pyramax^® tablets COVID-19 Drug repurposing	Pyramax^® tablets Malaria WHO-MMV
Infectious disease					Pyramax^® granules Malaria WHO-MMV
Platform technology	Fomulation Technology Controlled release, GRDDS, Double layer formulation, Tablet in Capsule, etc.
Platform technology	Long-acting nucleotide/peptide Research on months-long sustained effects of siRNA/peptide

Shinpoong Pharm.co.,LTd